Abbott Laboratories Management Discusses Q1 2012 Results – Earnings Call … – Seeking Alpha
Abbott Laboratories Management Discusses Q1 2012 Results – Earnings Call …Seeking AlphaDaclizumab is a next-generation biologic in development for MS. Last year, Abbott and our partner company announced promising results from the first of 2 registrat…
